Beranda › Trombosis Vena Dalam › Texas
Uji klinis Trombosis Vena Dalam di Texas
7 studi untuk Trombosis Vena Dalam mencari peserta di lokasi di Texas.
Kota di Texas
Teks studi resmi (Bahasa Inggris)
REGN7508 in Adult Participants for Prevention of Cancer-Associated Thrombosis
- El Paso Medical Research Institute (Medresearch Inc), El Paso
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 29 Sep 2026 · NCT07410117Perivenous Dexamethasone Therapy: Examining Reduction of Inflammation After Thrombus Removal to Yield Benefit in Acute Femoropopliteal DVT
- HCA Medical City Arlington, Arlington
- HCA Houston Healthcare Medical Center, Houston
- Baylor Scott & White Hospital, Plano
Menerima pesertaFase 2
Usia 18 hingga 89 · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT04862468REGN7508 Versus Acetylsalicylic Acid (ASA) for Venous Thromboprophylaxis After Total Knee Arthroplasty in Adult Participants
- NextStage Clinical Research, All American Orthopedics and Sports Medicine, Houston
- Flourish Research - San Antonio (Formerly Clinical Trials of Texas), San Antonio
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT07213778DEFIANCE: RCT of ClotTriever System Versus Anticoagulation In Deep Vein Thrombosis
- Clements University Hospital (UTSW), Dallas
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 9 Sep 2026 · NCT05701917Case-Specific Health Care Professional Clinical Survey of Liberant™ Thrombectomy System
- Baylor Heart Hospital Of Plano, Plano
Menerima pesertaStudi observasional
Usia 22 ke atas · Semua jenis kelamin · Diperbarui 11 Agu 2026 · NCT07335341Cleaner Long-tErm Assessment Registry - Venous Insights and Efficacy With eXtended Tracking
- Baylor Scott & White The Heart Hospital - Plano, Plano
Menerima pesertaStudi observasional
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 16 Jun 2026 · NCT07102160Catheter-Related Early Thromboprophylaxis With Enoxaparin Studies
- Dell Children's Medical Canter, Austin
- UTSW Medical Center; Children's Medical Center of Dallas, Dallas
Menerima pesertaFase 2/3
Hingga usia 17 · Semua jenis kelamin · Diperbarui 8 Jun 2026 · NCT04924322Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.